Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender

Claudia Penna1, Francesca Tullio, Annalisa Merlino

  • 1Dip. to di Scienze Cliniche e Biologiche, Università di Torino, Regione Gonzole 10, 10043, Orbassano, TO, Italy.

Insights

Cardioprotection by postconditioning (PostC) shows gender differences in reducing infarct size and systolic dysfunction after ischemia. PostC benefits females more for systolic function, suggesting an anti-necrotic rather than anti-stunning effect.

Area of Science:

  • Cardiovascular Physiology
  • Ischemic Heart Disease Research
  • Gender-Specific Medicine

Background:

  • Cardioprotection strategies aim to limit heart damage during ischemia-reperfusion injury.
  • The gender-specific effects of postconditioning (PostC) on myocardial infarct size (IS) and post-ischemic systolic dysfunction (PSD) remain unclear.

Purpose of the Study:

  • To investigate whether the cardioprotective effects of PostC are dependent on gender.
  • To evaluate the impact of PostC on reducing IS and PSD in male and female rat hearts subjected to varying ischemia durations.

Main Methods:

  • Isolated male and female rat hearts underwent global ischemia (10 or 30 minutes) followed by reperfusion (120 minutes).
  • Postconditioning was applied immediately after ischemia, consisting of 5 cycles of 10-second reperfusion/ischemia.
  • Infarct size (IS) and post-ischemic systolic dysfunction (PSD) were assessed. Contracture development and buffer perfusion effects were also monitored.

Main Results:

  • After 10-min ischemia, female hearts showed greater IS and PSD; PostC attenuated both in females only.
  • After 30-min ischemia, female hearts had smaller IS, but similar PSD compared to males.
  • PostC reduced IS in both genders (less effective in females) and PSD in females but not males. Contracture correlated with IS.

Conclusions:

  • Myocardial IS, contracture, and PSD are differentially affected by gender based on ischemia duration.
  • The reduction in IS by PostC is dependent on the extent of index-ischemia.
  • PostC's improvement of systolic function is primarily due to its anti-necrotic effects, particularly evident in females.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...